Advertisement

Basal Cell Carcinoma

Published:October 27, 2022DOI:https://doi.org/10.1016/j.det.2022.07.005

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Dermatologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rogers H.W.
        • Weinstock M.A.
        • Feldman S.R.
        • et al.
        Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
        JAMA Dermatol. 2015; 151: 1081-1086
      1. American Cancer Society. Cancer Statistics Center.
        (Available at:) (Accessed January 2)
        • Lear J.T.
        • Smith A.G.
        Basal cell carcinoma.
        Postgrad Med J. 1997; 73: 538-542
        • Rigel D.S.
        • Friedman R.J.
        • Kopf A.W.
        Lifetime risk for development of skin cancer in the U.S. population: current estimate is now 1 in 5.
        J Am Acad Dermatol. 1996; 35: 1012-1013
        • Wu S.
        • Han J.
        • Li W.Q.
        • et al.
        Basal-cell carcinoma incidence and associated risk factors in U.S. women and men.
        Am J Epidemiol. 2013; 178: 890-897
        • Abarca J.F.
        • Casiccia C.C.
        Skin cancer and ultraviolet-B radiation under the Antarctic ozone hole: southern Chile, 1987-2000.
        Photodermatol Photoimmunol Photomed. 2002; 18: 294-302
        • Sng J.
        • Koh D.
        • Siong W.C.
        • et al.
        Skin cancer trends among Asians living in Singapore from 1968 to 2006.
        J Am Acad Dermatol. 2009; 61: 426-432
        • Bath-Hextall F.
        • Leonardi-Bee J.
        • Smith C.
        • et al.
        Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study.
        Int J Cancer. 2007; 121: 2105-2108
        • Staples M.P.
        • Elwood M.
        • Burton R.C.
        • et al.
        Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985.
        Med J Aust. 2006; 184: 6-10
        • Khalesi M.
        • Whiteman D.C.
        • Tran B.
        • et al.
        A meta-analysis of pigmentary characteristics, sun sensitivity, freckling and melanocytic nevi and risk of basal cell carcinoma of the skin.
        Cancer Epidemiol. 2013; 37: 534-543
        • Zanetti R.
        • Rosso S.
        • Martinez C.
        • et al.
        Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study.
        Br J Cancer. 2006; 94: 743-751
        • van Dam R.M.
        • Huang Z.
        • Rimm E.B.
        • et al.
        Risk factors for basal cell carcinoma of the skin in men: results from the health professionals follow-up study.
        Am J Epidemiol. 1999; 150: 459-468
        • Lear J.T.
        • Tan B.B.
        • Smith A.G.
        • et al.
        Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients.
        J R Soc Med. 1997; 90: 371-374
        • Kricker A.
        • Armstrong B.K.
        • English D.R.
        • et al.
        Pigmentary and cutaneous risk factors for non-melanocytic skin cancer--a case-control study.
        Int J Cancer. 1991; 48: 650-662
        • Maia M.
        • Proença N.G.
        • de Moraes J.C.
        Risk factors for basal cell carcinoma: a case-control study.
        Rev Saude Publica. 1995; 29: 27-37
        • Gallagher R.P.
        • Hill G.B.
        • Bajdik C.D.
        • et al.
        Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma.
        Arch Dermatol. 1995; 131: 157-163
        • Karagas M.R.
        • Zens M.S.
        • Li Z.
        • et al.
        Early-onset basal cell carcinoma and indoor tanning: a population-based study.
        Pediatrics. 2014; 134: e4-e12
        • Gandini S.
        • Doré J.F.
        • Autier P.
        • et al.
        Epidemiological evidence of carcinogenicity of sunbed use and of efficacy of preventive measures.
        J Eur Acad Dermatol Venereol. 2019; 33: 57-62
        • Wehner M.R.
        • Shive M.L.
        • Chren M.M.
        • et al.
        Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis.
        Bmj. 2012; 345: e5909
        • Karagas M.R.
        • McDonald J.A.
        • Greenberg E.R.
        • et al.
        Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
        J Natl Cancer Inst. 1996; 88: 1848-1853
        • Preston D.L.
        • Ron E.
        • Tokuoka S.
        • et al.
        Solid cancer incidence in atomic bomb survivors: 1958-1998.
        Radiat Res. 2007; 168: 1-64
        • Lichter M.D.
        • Karagas M.R.
        • Mott L.A.
        • et al.
        Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group.
        Arch Dermatol. 2000; 136: 1007-1011
        • Watt T.C.
        • Inskip P.D.
        • Stratton K.
        • et al.
        Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study.
        J Natl Cancer Inst. 2012; 104: 1240-1250
        • Hartevelt M.M.
        • Bavinck J.N.
        • Kootte A.M.
        • et al.
        Incidence of skin cancer after renal transplantation in The Netherlands.
        Transplantation. 1990; 49: 506-509
        • Stern R.S.
        The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
        J Am Acad Dermatol. 2012; 66: 553-562
        • Wade T.R.
        • Ackerman A.B.
        The many faces of basal-cell carcinoma.
        J Dermatol Surg Oncol. 1978; 4: 23-28
        • McCormack C.J.
        • Kelly J.W.
        • Dorevitch A.P.
        Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes.
        Arch Dermatol. 1997; 133: 593-596
        • Scrivener Y.
        • Grosshans E.
        • Cribier B.
        Variations of basal cell carcinomas according to gender, age, location and histopathological subtype.
        Br J Dermatol. 2002; 147: 41-47
      2. NCCN. Basal Cell Skin Cancer (Version 1.2022).
        (Available at:) (Accessed January 8, 2022)
        • Amin M.
        • Edge S.
        • Greene F.
        • et al.
        AJCC cancer staging manual.
        8th edition. Springer Publishing, New York2017
        • Morgan F.C.
        • Ruiz E.S.
        • Karia P.S.
        • et al.
        Brigham and Women's Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death.
        J Am Acad Dermatol. 2021; 85: 582-587
        • Domarus H.V.
        • Stevens P.J.
        Metastatic basal cell carcinoma: Report of five cases and review of 170 cases in the literature.
        J Am Acad Dermatol. 1984; 10: 1043-1060
        • Lo J.S.
        • Snow S.N.
        • Reizner G.T.
        • et al.
        Metastatic basal cell carcinoma: Report of twelve cases with a review of the literature.
        J Am Acad Dermatol. 1991; 24: 715-719
        • Snow S.N.
        • Sahl W.
        • Lo J.S.
        • et al.
        Metastatic basal cell carcinoma. Report of five cases. Article.
        Cancer. 1994; 73: 328-335
        • Wysong A.
        • Aasi S.Z.
        • Tang J.Y.
        Update on Metastatic Basal Cell Carcinoma: A Summary of Published Cases From 1981 Through 2011.
        JAMA Dermatol. 2013; 149: 615-616
        • McCusker M.
        • Basset-Seguin N.
        • Dummer R.
        • et al.
        Metastatic basal cell carcinoma: Prognosis dependent on anatomic site and spread of disease.
        Eur J Cancer. 2014; 50: 774-783
        • Morgan F.C.
        • Ruiz E.S.
        • Karia P.S.
        • et al.
        Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2 cm or larger in diameter.
        J Am Acad Dermatol. 2020; 83: 832-838
        • Reiter O.
        • Mimouni I.
        • Gdalevich M.
        • et al.
        The diagnostic accuracy of dermoscopy for basal cell carcinoma: A systematic review and meta-analysis.
        J Am Acad Dermatol. 2019; 80: 1380-1388
        • Nwaneshiudu A.
        • Kuschal C.
        • Sakamoto F.H.
        • et al.
        Introduction to Confocal Microscopy.
        J Invest Dermatol. 2012; 132: 1-5
        • Xiong Y.D.
        • Ma S.
        • Li X.
        • et al.
        A meta-analysis of reflectance confocal microscopy for the diagnosis of malignant skin tumours.
        J Eur Acad Dermatol Venereol. 2016; 30: 1295-1302
        • Woliner-van der Weg W.
        • Peppelman M.
        • Elshot Y.S.
        • et al.
        Biopsy outperforms reflectance confocal microscopy in diagnosing and subtyping basal cell carcinoma: results and experiences from a randomized controlled multicentre trial.
        Br J Dermatol. 2021; 184: 663-671
        • Ulrich M.
        • von Braunmuehl T.
        • Kurzen H.
        • et al.
        The sensitivity and specificity of optical coherence tomography for the assisted diagnosis of nonpigmented basal cell carcinoma: an observational study.
        Br J Dermatol. 2015; 173: 428-435
        • Jørgensen T.M.
        • Tycho A.
        • Mogensen M.
        • et al.
        Machine-learning classification of non-melanoma skin cancers from image features obtained by optical coherence tomography.
        Skin Res Technol. 2008; 14: 364-369
        • Mogensen M.
        • Joergensen T.M.
        • Nürnberg B.M.
        • et al.
        Assessment of optical coherence tomography imaging in the diagnosis of non-melanoma skin cancer and benign lesions versus normal skin: observer-blinded evaluation by dermatologists and pathologists.
        Dermatol Surg. 2009; 35: 965-972
        • Parashar K.
        • Torres A.E.
        • Boothby-Shoemaker W.
        • et al.
        Imaging Technologies for Pre-surgical Margin Assessment of Basal Cell Carcinoma.
        J Am Acad Dermatol. 2021; https://doi.org/10.1016/j.jaad.2021.11.010
        • Barlow J.O.
        • Zalla M.J.
        • Kyle A.
        • et al.
        Treatment of basal cell carcinoma with curettage alone.
        J Am Acad Dermatol. 2006; 54: 1039-1045
        • Thissen M.R.T.M.
        • Neumann M.H.A.
        • Schouten L.J.
        A Systematic Review of Treatment Modalities for Primary Basal Cell Carcinomas.
        Arch Dermatol. 1999; 135: 1177-1183
        • Blixt E.
        • Nelsen D.
        • Stratman E.
        Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
        Dermatol Surg. 2013; 39: 719-725
        • Rodriguez-Vigil T.
        • Vázquez-López F.
        • Perez-Oliva N.
        Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
        J Am Acad Dermatol. 2007; 56: 91-95
        • Kopf A.W.
        • Bart R.S.
        • Schrager D.
        • et al.
        Curettage-electrodesiccation treatment of basal cell carcinomas.
        Arch Dermatol. 1977; 113: 439-443
        • Armstrong L.T.D.
        • Magnusson M.R.
        • Guppy M.P.B.
        Risk factors for recurrence of facial basal cell carcinoma after surgical excision: A follow-up analysis.
        J Plast Reconstr Aesthet Surg. 2017; 70: 1738-1745
        • Wolf D.J.
        • Zitelli J.A.
        Surgical margins for basal cell carcinoma.
        Arch Dermatol. 1987; 123: 340-344
        • van Loo E.
        • Mosterd K.
        • Krekels G.A.
        • et al.
        Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up.
        Eur J Cancer. 2014; 50: 3011-3020
        • Kondo R.N.
        • Gon A.D.S.
        • Pontello Junior R.
        Recurrence rate of basal cell carcinoma in patients submitted to skin flaps or grafts.
        An Bras Dermatol. 2019; 94: 442-445
        • Quirk C.
        • Gebauer K.
        • De'Ambrosis B.
        • et al.
        Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study.
        Cutis. 2010; 85: 318-324
        • Schulze H.J.
        • Cribier B.
        • Requena L.
        • et al.
        Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
        Br J Dermatol. 2005; 152: 939-947
        • Arits A.H.
        • Mosterd K.
        • Essers B.A.
        • et al.
        Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
        Lancet Oncol. 2013; 14: 647-654
        • Roozeboom M.H.
        • Arits A.
        • Mosterd K.
        • et al.
        Three-Year Follow-Up Results of Photodynamic Therapy vs. Imiquimod vs. Fluorouracil for Treatment of Superficial Basal Cell Carcinoma: A Single-Blind, Noninferiority, Randomized Controlled Trial.
        J Invest Dermatol. 2016; 136: 1568-1574
        • Wang I.
        • Bendsoe N.
        • Klinteberg C.A.
        • et al.
        Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial.
        Br J Dermatol. 2001; 144: 832-840
        • Basset-Seguin N.
        • Ibbotson S.H.
        • Emtestam L.
        • et al.
        Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial.
        Eur J Dermatol. 2008; 18: 547-553
        • Hall V.L.
        • Leppard B.J.
        • McGill J.
        • et al.
        Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy.
        Clin Radiol. 1986; 37: 33-34
        • Wang H.
        • Xu Y.
        • Shi J.
        • et al.
        Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis.
        Photodermatol Photoimmunol Photomed. 2015; 31: 44-53
        • Rowe D.E.
        • Carroll R.J.
        • Day Jr., C.L.
        Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up.
        J Dermatol Surg Oncol. 1989; 15: 315-328
        • Rowe D.E.
        • Carroll R.J.
        • Day Jr., C.L.
        Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma.
        J Dermatol Surg Oncol. 1989; 15: 424-431
        • Avril M.F.
        • Auperin A.
        • Margulis A.
        • et al.
        Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study.
        Br J Cancer. 1997; 76: 100-106
        • Thomson J.
        • Hogan S.
        • Leonardi-Bee J.
        • et al.
        Bath-Hextall FJ. Interventions for basal cell carcinoma: abridged Cochrane systematic review and GRADE assessments.
        Br J Dermatol. 2021; 185: 499-511
        • Likhacheva A.
        • Awan M.
        • Barker C.A.
        • et al.
        Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline.
        Pract Radiat Oncol. 2020; 10: 8-20
        • Epstein E.H.
        Basal cell carcinomas: attack of the hedgehog.
        Nat Rev Cancer. 2008; 8: 743-754
        • Campione E.
        • Di Prete M.
        • Lozzi F.
        • et al.
        High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature.
        Chemotherapy. 2020; 65: 2-10
        • Kim D.J.
        • Kim J.
        • Spaunhurst K.
        • et al.
        Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma.
        J Clin Oncol. 2014; 32: 745-751
        • Moeholt K.
        • Aagaard H.
        • Pfeiffer P.
        • et al.
        Platinum-based cytotoxic therapy in basal cell carcinoma--a review of the literature.
        Acta Oncol. 1996; 35: 677-682
        • Green A.
        • Williams G.
        • Neale R.
        • et al.
        Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial.
        Lancet. 1999; 354: 723-729
        • Sánchez G.
        • Nova J.
        • Rodriguez-Hernandez A.E.
        • et al.
        Sun protection for preventing basal cell and squamous cell skin cancers.
        Cochrane Database Syst Rev. 2016; 7: Cd011161
        • Chen A.C.
        • Martin A.J.
        • Choy B.
        • et al.
        A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
        N Engl J Med. 2015; 373: 1618-1626
        • Wu S.
        • Cho E.
        • Li W.Q.
        • et al.
        History of Keratinocyte Carcinoma and Risk of Melanoma: A Prospective Cohort Study.
        J Natl Cancer Inst. 2017; 109
        • Wehner M.R.
        • Linos E.
        • Parvataneni R.
        • et al.
        Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
        JAMA Dermatol. 2015; 151: 382-388
        • Revenga F.
        • Paricio J.F.
        • Vázquez M.M.
        • et al.
        Risk of subsequent non-melanoma skin cancer in a cohort of patients with primary basal cell carcinoma.
        J Eur Acad Dermatol Venereol. 2004; 18: 514-515